# Spark Neuro

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/spark-neuro

- Industry: Business Support Services
- Headquarters: New York, US
- Website: www.sparkneuro.com
- Total disclosed funding: $13M
- Latest round: Series A (Jul 18, 2018)
- Investors on record: 1

## About

Spark Neuro Inc. offers advanced cognitive care solutions focused on improving dementia diagnosis and management through innovative diagnostic tools and tailored care plans for healthcare providers.Founded in 2016, Spark Neuro Inc. is headquartered in New York, US, and specializes in cognitive care solutions aimed at enhancing dementia diagnosis. The company has engaged in two funding deals, with the most recent being a Series A round in November 2018 where it raised USD 13.29 mn led by Valar. Spencer Gerrol serves as both CEO and Founder.SPARK Neuro specializes in advanced cognitive care solutions aimed at improving the diagnosis and management of dementia. The company’s core offerings involve a comprehensive approach to identifying high-risk individuals for dementia through innovative diagnostic tools and tailored care plans. By streamlining the assessment process, SPARK Neuro addresses the significant gap in early detection, with nearly 40% of dementia cases going undiagnosed in the U.S. The primary clientele includes primary care physicians (PCPs) and healthcare providers seeking to enhance their diagnostic capabilities, particularly in urban healthcare markets where the demand for neurological services is escalating.SPARK Neuro's revenue model is primarily structured around partnerships with healthcare providers and subscription-based services for their cognitive assessment tools. The company engages with PCPs and healthcare systems to provide ongoing access to its diagnostic technology, facilitating timely evaluations and care planning for patients at risk of dementia. Clients typically engage with SPARK Neuro through structured agreements, enabling them to integrate the company’s solutions into their existing workflows. The company’s offerings are positioned as essential tools in enhancing the quality of dementia care, driving potential cost savings and efficiencies for healthcare providers.Following its Series A funding round in November 2018, Spark Neuro Inc. is focused on developing new products aimed at further enhancing its diagnostic capabilities for dementia. The company is also planning to expand its reach into new markets, particularly targeting urban areas across the United States where the demand for cognitive care solutions is increasing. Recent funding will support the development of these initiatives, allowing Spark Neuro to strengthen its position in the healthcare market.

## Funding rounds

- Series A, Jul 18, 2018, $13M — Valar

## Investors

- Valar (https://capitalatlas.ai/funds/valar) — Series A